BCAB vs BR · $5.9M cap vs P/E 16, rev $6.89B
Bioatla Inc (BCAB) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported BR revenue for 2025-06-30 was $6.89B. Net income was $839.5M. Revenue was up 5.9% from 2024-06-30 to 2025-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
BCAB currently screens at market cap $5.9M. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the BCAB and BR stock pages for the full models.
Not investment advice.